Rh-Catalyzed C–H alkylation enabling modular synthesis of CF3-substituted benzannulated macrocyclic inhibitors of B cell responses
Tao Sun
1, 2, 3, 4, 5
,
Shijun He
5, 6, 7, 8, 9, 10, 11
,
Zhongliang Xu
5, 6, 8, 9, 10, 11
,
Jian-ping Zuo
6, 7
,
Jianping Zuo
5, 8, 9, 10, 11
,
Yang Yu
1, 2, 3, 4, 5
,
Weibo Yang
5, 6, 7, 8, 9, 10, 11, 12
2
Center for Supramolecular Chemistry and Catalysis and Department of Chemistry
4
Shanghai 200444
|
5
CHINA
|
8
Chinese Academy of Sciences Key Laboratory of Receptor Research
10
Chinese Academy of sciences
11
Shanghai
|
Publication type: Journal Article
Publication date: 2021-03-24
scimago Q2
wos Q2
SJR: 0.600
CiteScore: 5.2
Impact factor: 2.7
ISSN: 14770520, 14770539
PubMed ID:
33908550
Organic Chemistry
Biochemistry
Physical and Theoretical Chemistry
Abstract
Inspired by aspirin and chalcone, herein, we describe a modular biomimetic strategy to achieve a new class of CF3-bearing benzannulated macrolactams. The key to the success of macrolactams was the utilization of a highly chemoselective Rh(iii)-catalyzed native carboxylic acid-directed C-H alkylation. Moreover, the unique CF3-containing benzannulated macrocycles showed decent immunosuppressive effects on B cells in vitro, including proliferation, activation, and antibody production upon specific stimulation implicating TLR and BCR signaling.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
|
|
|
Chem
1 publication, 12.5%
|
|
|
Angewandte Chemie - International Edition
1 publication, 12.5%
|
|
|
Angewandte Chemie
1 publication, 12.5%
|
|
|
Journal of Organic Chemistry
1 publication, 12.5%
|
|
|
European Journal of Organic Chemistry
1 publication, 12.5%
|
|
|
Journal of Materials Chemistry B
1 publication, 12.5%
|
|
|
Organic and Biomolecular Chemistry
1 publication, 12.5%
|
|
|
Organic Letters
1 publication, 12.5%
|
|
|
1
|
Publishers
|
1
2
3
|
|
|
Wiley
3 publications, 37.5%
|
|
|
American Chemical Society (ACS)
2 publications, 25%
|
|
|
Royal Society of Chemistry (RSC)
2 publications, 25%
|
|
|
Elsevier
1 publication, 12.5%
|
|
|
1
2
3
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
8
Total citations:
8
Citations from 2024:
3
(37.5%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Sun T. et al. Rh-Catalyzed C–H alkylation enabling modular synthesis of CF3-substituted benzannulated macrocyclic inhibitors of B cell responses // Organic and Biomolecular Chemistry. 2021. Vol. 19. No. 16. pp. 3589-3594.
GOST all authors (up to 50)
Copy
Sun T., He S., Xu Z., Zuo J., Zuo J., Yu Y., Yang W. Rh-Catalyzed C–H alkylation enabling modular synthesis of CF3-substituted benzannulated macrocyclic inhibitors of B cell responses // Organic and Biomolecular Chemistry. 2021. Vol. 19. No. 16. pp. 3589-3594.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1039/d1ob00296a
UR - https://xlink.rsc.org/?DOI=D1OB00296A
TI - Rh-Catalyzed C–H alkylation enabling modular synthesis of CF3-substituted benzannulated macrocyclic inhibitors of B cell responses
T2 - Organic and Biomolecular Chemistry
AU - Sun, Tao
AU - He, Shijun
AU - Xu, Zhongliang
AU - Zuo, Jian-ping
AU - Zuo, Jianping
AU - Yu, Yang
AU - Yang, Weibo
PY - 2021
DA - 2021/03/24
PB - Royal Society of Chemistry (RSC)
SP - 3589-3594
IS - 16
VL - 19
PMID - 33908550
SN - 1477-0520
SN - 1477-0539
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_Sun,
author = {Tao Sun and Shijun He and Zhongliang Xu and Jian-ping Zuo and Jianping Zuo and Yang Yu and Weibo Yang},
title = {Rh-Catalyzed C–H alkylation enabling modular synthesis of CF3-substituted benzannulated macrocyclic inhibitors of B cell responses},
journal = {Organic and Biomolecular Chemistry},
year = {2021},
volume = {19},
publisher = {Royal Society of Chemistry (RSC)},
month = {mar},
url = {https://xlink.rsc.org/?DOI=D1OB00296A},
number = {16},
pages = {3589--3594},
doi = {10.1039/d1ob00296a}
}
Cite this
MLA
Copy
Sun, Tao, et al. “Rh-Catalyzed C–H alkylation enabling modular synthesis of CF3-substituted benzannulated macrocyclic inhibitors of B cell responses.” Organic and Biomolecular Chemistry, vol. 19, no. 16, Mar. 2021, pp. 3589-3594. https://xlink.rsc.org/?DOI=D1OB00296A.
Profiles